For Research and Development scientists in the pharmaceutical sector, the selection of chemical building blocks is fundamental to the success of their drug discovery and development programs. 2,6-Diaminopurine Arabinoside (CAS 34079-68-0) stands out as a key intermediate with significant applications in the synthesis of antiviral and anticancer drugs. Understanding the nuances of procuring this compound is therefore essential for efficient laboratory operations and robust drug candidate development.

When a scientist needs to buy 2,6-Diaminopurine Arabinoside, several factors come into play. Foremost is the purity of the compound. A high assay, typically 98.0% or greater as confirmed by HPLC, is critical to ensure predictable reaction outcomes and to avoid the introduction of confounding impurities into complex synthesis pathways. Low moisture content, specified as ≤1.0% loss on drying, is also vital, as water can interfere with sensitive chemical reactions.

Availability from a reliable 2,6-Diaminopurine Arabinoside supplier is another key consideration. Consistent stock levels and predictable delivery times prevent research delays. For R&D departments working on novel therapies, the ability to purchase 2,6-Diaminopurine Arabinoside in various quantities, from milligrams for initial screening to kilograms for scale-up studies, is highly advantageous. Many leading manufacturers, particularly those based in China, offer this flexibility.

Furthermore, understanding the chemical characteristics of the intermediate is important for experimental design. Its physical form as a white or off-white crystalline powder, its molecular weight (282.25600 g/mol), and its stability under various conditions all inform how it can be best utilized in the lab. Seeking out a 2,6-Diaminopurine Arabinoside manufacturer that provides comprehensive technical data supports informed decision-making.

The cost-effectiveness of procuring 2,6-Diaminopurine Arabinoside can also impact research budgets. Direct sourcing from manufacturers often provides better value, enabling more extensive experimentation or larger-scale pilot studies. In conclusion, for R&D scientists, a strategic approach to purchasing this vital pharmaceutical intermediate—focusing on purity, reliability, and technical support—is key to advancing the frontiers of medicine.